Children's Hospital Los Angeles
Dr. Deepa Bhojwani is the Director of the Leukemia and Lymphoma Program at Children’s Hospital, Los Angeles (CHLA). She completed her training in pediatric hematology and oncology at New York University Medical Center, then served for 7 years at St Jude Children’s Research Hospital in Memphis, TN before joining CHLA in 2015. Her research background is in relapsed acute lymphoblastic leukemia (ALL) and includes studies of molecular pathways leading to relapse, identification of potential new therapeutic targets using high-throughput genomics and follow up validation in pre-clinical models. Together with patient care, she is primarily involved in clinical and translational research. She has been appointed as the Vice-Chair for Relapsed ALL at the Children’s Oncology Group, and the Associate Medical Director of the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) consortium. She also serves as a scientific advisor for the Leukemia Lymphoma Society Children’s Initiative. She collaborates with pediatric oncologists and researchers nationally and internationally, and has developed and conducted several clinical trials of new drugs in leukemia and lymphoma.
Some of Dr. Bhojwani’s other interests include developing strategies to decrease the side effects of chemotherapy, reducing ethnic disparities in leukemia outcome and improving the care of children with cancer in countries with limited resources.
Developing Therapy for Every Kid with Cancer
Friday, March 24, 2023
9:30 AM – 10:30 AM EDT